Texas A&M study shows small, consistent physical
Author: Michael
Aviceda Therapeutics announced topline results fr
Longevity experts say you don’t need supplemen
New health platform converts labs, wearables and
Initial focus on epilepsy could drive progress i
Phase III trial shows up to 28.
AB Science announced the publication of a new pre
Serina Therapeutics announced the appointment of
Bets on automation underscore investor confidenc
A heart surgeon and heart attack survivor shares